Review article: Transient lower oesophageal sphincter relaxations - A pharmacological target for gastro-oesophageal reflux disease?

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 1, 2002, Pages 17-26

  Hirsch, D P ^a   Tytgat, G N J ^a   Boeckxstaens, G E E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BACLOFEN; DEVAZEPIDE; LOXIGLUMIDE; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; RILUZOLE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; HORMONE ANTAGONIST; PROGLUMIDE;

BARRETT ESOPHAGUS; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; LOWER ESOPHAGUS SPHINCTER; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; DRUG EFFECT; GASTROINTESTINAL ENDOSCOPY; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VAGUS NERVE;

ATROPINE; BACLOFEN; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGOGASTRIC JUNCTION; FUNDOPLICATION; GABA AGONISTS; GASTROESOPHAGEAL REFLUX; HORMONE ANTAGONISTS; HUMANS; PARASYMPATHOLYTICS; PROGLUMIDE; VAGUS NERVE;

EID: 0036163950     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01153.x     Document Type: Review

References (98)

1. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease
2. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
3. Risk factors for irritable bowel syndrome: Role of analgesics and food sensitivities
4. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus
5. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and nissen fundoplication
6. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
7. Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease
8. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of 'abnormal' contractions
9. Normal lower esophageal sphincter pressure: A comparison of rapid vs. slow pull-through techniques
10. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
11. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans
12. Electrical and mechanical inhibition of the crural diaphragm during transient relaxation of the lower esophageal sphincter
13. Mediation by nitric oxide of TRH-, but not metoclopramide-stimulated TSH secretion in humans
14. Effect of esophageal emptying and saliva on clearance of acid from the esophagus
15. Acid neutralizing capacity of human saliva
16. Role of salivary mucin in the protection of rat esophageal mucosa from acid and pepsin-induced injury
17. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux
18. Gastroesophageal reflux in healthy subjects. Significance of endoscopic findings, histology, age, and sex
19. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
20. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease
21. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender
22. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
23. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects
24. Criteria for objective definition of transient lower esophageal sphincter relaxation
25. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux
26. Involvement of cholecystokinin-A receptors in transient lower esophageal sphincter relaxations triggered by gastric distension
27. Gastric distension: A mechanism for postprandial gastroesophageal reflux
28. Response of canine lower esophageal sphincter to gastric distension
29. Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog
30. Triggering of transient LES relaxations in ferrets: Role of sympathetic pathways and effects of baclofen
31. Sensory vagal innervation of the rat esophagus and cardia: A light and electron microscopic anterograde tracing study
32. Viscerotopic representation of the upper alimentary tract in the rat: Sensory ganglia and nuclei of the solitary and spinal trigeminal tracts
33. Brainstem projections of sensory and motor components of the vagus nerve in the rat
34. Brain stem response to phasic gastric distension
35. Ultrastructural demonstration of a gastric monosynaptic vagal circuit in the nucleus of the solitary tract in rat
36. Ultrastructure and synaptology of the nucleus ambiguus in the rat: The compact formation
37. Lower esophageal sphincter relaxation and activation of medullary neurons by subdiaphragmatic vagal stimulation in the mouse
38. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis
39. Transient LES relaxations: Are they more frequent in patients with gastroesophageal reflux disease?
40. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)
41. Determinants of gastro-oesophageal reflux and their inter-relationships
42. The effect of hiatus hernia on gastro-oesophageal junction pressure
43. Impairment of esophageal emptying with hiatal hernia
44. Effect of hiatal hernia on esophageal manometry and pH-metry in gastroesophageal reflux disease
45. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia
46. Gastroesophageal reflux after combined lower esophageal sphincter and diaphragmatic crural sling inactivation in the rat
47. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects
48. The esophagogastric junction
49. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying
50. Reflex inhibition of crural diaphragmatic activity by esophageal distention in cats
51. Evidence for a peripheral mechanism of esophagocrural diaphragm inhibitory reflex in cats
52. Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease
53. Intragastric maldistribution in patients with reflux oesophagitis studied by an accurate 3D ultrasound system
54. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease
55. Atropine inhibits gastric distention and pharyngeal receptor mediated lower oesophageal sphincter relaxation
56. Cholecystokinin in transient lower esophageal sphincter relaxation due to gastric distension in man
57. Inhibition of TLESRs by atropine reexamined: Primary or secondary effect?
58. Involvement of cholecystokinin-A receptors in transient lower esophageal sphincter relaxations triggered by gastric distention
59. Mechanisms of gastro-oesophageal reflux in the ferret
60. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans
61. Effect of atropine on proximal gastric motor and sensory function in normal subjects
62. Activation of the GABA (B) receptor inhibits transient lower esophageal sphincter relaxations in dogs
63. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects
64. Involvement of glutamate in transient lower esophageal sphincter relaxations
65. Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs
66. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis
67. Effect of L-NMMA on post-prandial transient lower esophageal sphincter relaxations in healthy volunteers
68. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation
69. Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism
70. Rate of transient lower esophageal sphincter relaxations during prolonged gastric distension
71. Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention
72. Co-localization of NOS and NMDA receptor in esophageal premotor neurons of the rat
73. Ultrastructure of glutamate and GABA immunoreactive axon terminals of the rat nucleus tractus solitarius, with a note on infralimbic cortex afferents
74. Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists
75. GABA (B) receptors inhibit mechanosensitivity of primary afferent endings
76. The gastrointestinal effects of baclofen are limited to the proximal part of the GI tract
77. Cardiovascular effects of nitric oxide and N-methyl-D-aspartate receptors in the nucleus tractus solitarii of rats
78. Glutamate receptor subunits in the nucleus of the tractus solitarius and other regions of the medulla oblongata in the cat
79. Demonstration of glutamate immunoreactivity in vagal sensory afferents in the nucleus tractus solitarius of the rat
80. Glutamate, nitric oxide and cell-cell signalling in the nervous system
81. Anatomy and physiology of glutamate in the CNS
82. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors
83. Mechanisms underlying the anti-reflux action of fundoplication
84. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux
85. Complications associated with laparoscopic anti-reflux surgery: One multispecialty clinic's experience
86. Transoral, flexible endoscopic suturing for treatment of GERD, a multicenter trial
87. Radiofrequency energy delivered to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation in a canine model
88. Efficacy of radiofrequency energy delivered to the lower esophageal sphincter in the treatment of GERD
89. Reduction of reflux events by blockade of gastric mechanoreceptors: A novel approach
90. New developments in esophageal manometry: Portable water-perfused manometric system to record lower esophageal sphincter pressure and automated signal analysis
91. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized
92. Validation studies of Bilitec 2000: An ambulatory duodenogastric reflux monitoring system
93. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: A study using intraluminal electrical impedance
94. Blockade of endogenous nitric oxide production results in moderate hypertension, reducing sympathetic activity and shortening bleeding time in healthy volunteers
95. Single- and multiple-dose pharmacokinetics of riluzole in white subjects